Relationship between anti-oxidant activities and doxorubicin-induced lipid peroxidation in P388 tumour cells and heart and liver in mice

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 3, 2003, Pages 185-188

  Liu, Qi Yuan ^a   Tan, Benny K H ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anti oxidant enzymes; Doxorubicin; Mice; P388

Indexed keywords

CATALASE; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART; LIPID PEROXIDATION; LIVER; MOUSE; NONHUMAN; PERITONEAL CAVITY; TUMOR CELL CULTURE;

ANIMALS; ANTIOXIDANTS; DOXORUBICIN; LEUKEMIA P388; LIPID PEROXIDATION; LIVER; MICE; MICE, INBRED DBA; MYOCARDIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037346067     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03803.x     Document Type: Article

References (31)

1. Carter SK. Adriamycin: A review. J. Natl Cancer Inst. 1975; 55: 1265-74.
2. Berlin V, Haseltine WA. Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J. Biol. Chem. 1981; 256: 4747-56.
3. Doroshow JH. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide and hydroxyl radical production by NADH dehydrogenase. Cancer Res. 1983; 43: 4543-51.
4. Pan SS, Bachur NR. Xanthine oxidase catalyzed reductive cleavage of anthracycline antibiotics and free radical formation. Mol. Pharmacol. 1980; 17: 95-9.
5. Lown JW, Chen HH, Plambeck JA, Acton EM. Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects. Biochem. Pharmacol. 1982; 31: 575-81.
6. Myers C, Gianni L, Zweier J, Muindi J, Sinha BK, Eliot H. Role of iron in adriamycin biochemistry. Fed. Proc. 1986; 45: 2792-7.
7. Gutteridge JM. Lipid peroxidation initiated by superoxide-dependent hydroxyl radicals using complexed iron and hydrogen peroxide. FEBS Lett. 1984; 172: 245-9.
8. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990; 186: 407-21.
9. Bird RP, Draper HH. Effect of malonaldehyde and acetaldehyde on cultured mammalian cells. Growth, morphology, and synthesis of macromolecules. J. Toxicol. Env. Health 1980; 6: 811-23.
10. Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J. Clin. Invest. 1980; 65: 128-35.
11. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 1977; 197: 165-7.
12. Yuan YV, Kitts DD, Godin DV. Variations in dietary fat and cholesterol intakes modify antioxidant status of SHR and WKY rats. J. Nutr. 1998; 128: 1620-30.
13. Youdim KA, Deans SG. Dietary supplementation of thyme (Thymus vulgaris L.) essential oil during the lifetime of the rat: Its effects on the antioxidant status in liver, kidney and heart tissues. Mech. Ageing Dev. 1999; 109: 163-75.
14. Reeves PG, Nielssen FH, Fahey GC. AIN-93G purified diets for laboratory rodents. Final report of the American Institute of Nutrition Ad Hoc Committee on the reformation of the AIN-76A rodent diet. J. Nutr. 1993; 123: 1939-51.
15. Alderton P, Gross J, Green MD. Role of (+)-1,2-bis (3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy. Cancer Res. 1990; 50: 5136-42.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
17. Kang YJ, Chen Y, Epstein PN. Suppression of doxorubicin by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 1996; 271: 12 610-16.
18. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 1974; 47: 469-74.
19. Beutler E. Catalase. In: Beutler E (ed.). Red Cell Metabolism: A Manual of Biochemical Methods. Grune & Stratton, New York. 1984; 105-6.
20. Beutler E. Glutathione peroxidase. In: Beutler E (ed.). Red Cell Metabolism: A Manual of Biochemical Methods. Grune & Stratton, New York. 1984; 74-5.
21. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett. 1998; 423: 275-80.
22. Ling YH, Pribe W, Perez-Soler R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res. 1993; 53: 1845-52.
23. Liochev S, Fridovich I. How does superoxide dismutase protect against tumor necrosis factor. A hypothesis informed by effect of superoxide on 'free' iron. Free Radic. Biol. Med. 1997; 23: 668-71.
24. Myers C. Role of iron in doxorubicin-induced cardiomyopathy. Semin. Oncol. 1998; 25: 10-14.
25. Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PM. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J. Clin. Invest. 1997; 100: 1501-6.
26. Li S, Yah T, Yang JQ, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 2000; 60: 3927-39.
27. Blum RH, Carter SK. Adriamycin. A new anticancer drug with significant clinical activity. Ann. Intern. Med. 1974; 80: 249-59.
28. Danesi R, Conte PF, Tacca MD. Pharmacokinetic optimisation of treatment schedules for anthracyclines and paclitaxel in patients with cancer. Clin. Pharmacokinet. 1999; 37: 195-211.
29. Greene RF, Collins JM, Jenkins JF, Spever JL, Myers CE. Plasma pharmacokinetics of adriamycin and adriamycinol: Implications for the design of in vitro experiments and treatment protocols. Cancer Res. 1983; 43: 3417-21.
30. Pacciarini MA, Barbieri B, Colombo T, Broggini M, Garattini S, Donelli MG. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. Cancer Treat. Rep. 1978; 62: 791-800.
31. Liu QY, Tan BKH. Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice. Lipids 2002; 37: 549-56.